Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research links mitochondrial dysfunction to postoperative cognitive decline. Learn what the science suggests and how emerging therapies may help protect brain health.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives postoperative cognitive decline and which targeted therapies show neuroprotective promise in preclinical studies.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives postoperative cognitive decline and which peptide-based therapies show promise in preclinical studies.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction and cognitive decline in aged rats. Learn what the findings mean for patients.
By Peptide Association Research Team
New research on GHK-Cu peptide in aged mice suggests delivery route may shape cognitive and molecular outcomes. Learn what the findings mean for aging research.
By Peptide Association Research Team
New research reveals how NAD+ may help restore brain function in Alzheimer's disease through REST protein modulation. Study findings and clinical implications.
By Peptide Association Research Team